Evaluation of a tool to predict diabetes' technology usage in children and adolescents using, or about to commence, continuous subcutaneous insulin infusion (CSII) for type 1 diabetes mellitus.

The Royal Childrens Hospital0 个研究点目标入组 100 人开始时间: 2011年10月5日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Inclusion Criteria
•Patients will be considered eligible if they are :
•-Over the age of 8yrs
•-Have a diagnosis of Type 1 Diabetes Mellitus
•-Have been using a Medtronic insulin pump compatible with the MiniLink CGM device for >6mths (CGM arm of study)
•-Home computer with e-mail access
•-English language comprehension

•Exclusion Criteria
•-Previous self-initiated use of a continuous glucose monitoring system (this does not exclude clinician initiated previous short term use of one sensor to elucidate glycaemic patterns)
•-Concurrent dermatological disorder e.g. keloid propensity or previous documented hypersensitivity to medical adhesives
•-Impaired vision such that the user would be unable to read the CGM data
•-Other medical condition or use of a medication that in the judgement of the investigator could affect wearing of a CGM sensor on a daily basis
•-Pregnancy

发起方

The Royal Childrens Hospital